003000.KS
Bukwang Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 4,040.00
−0.62%Margins
Gross margin
45.9%
EBITDA margin
7.8%
EBIT margin
5.4%
Net margin
4.1%
FCF margin
-2.1%
2.7%
Return on equity
1.9%
Return on assets
2.8%
Return on invested capital
0.46x
Asset turnover
KRW 3.4B
Cash from operations
KRW 1.7K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026